Ordering Recommendation

Use to detect neuron specific enolase, which may be a nonspecific marker of neuronal damage.

New York DOH Approval Status

This test is New York state approved.

Specimen Required

Patient Preparation
Collect

CSF.

Specimen Preparation

Separate from cells within 1 hour of collection. Transfer 0.5 mL CSF to an ARUP Standard Transport Tube. (Min: 0.5 mL)

Storage/Transport Temperature

Refrigerated

Unacceptable Conditions

Hemolyzed specimens.

Remarks
Stability

Ambient: Unacceptable; Refrigerated: 1 week; Frozen: 1 year (avoid repeated freeze/thaw cycles)

Methodology

Quantitative Immunoassay

Performed

Mon, Wed, Fri

Reported

1-8 days

Reference Interval

Less than or equal to 21.5 ng/mL

Interpretive Data

This test is performed using the BRAHMS NSE Kryptor Immunoassay. Results obtained with different methods or kits cannot be used interchangeably. Results cannot be interpreted as absolute evidence of the presence or absence of malignant disease.

Compliance Category

Laboratory Developed Test (LDT)

Note

Hotline History

N/A

CPT Codes

86316

Components

Component Test Code* Component Chart Name LOINC
3004315 Neuron Specific Enolase_CSF 47053-4
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.

Aliases

  • NSE
Neuron Specific Enolase, CSF